Worth noting was the significantly reduced concentrations of IL-6 observed in the ibuprofen treatment group at four days post-treatment, compared with the EPA/DHA supplemented group, supporting the previously observed association of ibuprofen treatment on IL-6 levels, as was seen in cystic fibrosis patients (61). This evidence concerns the gene IL6 and cystic fibrosis.